HEMAKE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
HEMAKE
Largest movements
- Current investments -€220,000
no longer reported in 2025 (was €220,000)
- Receivables within one year +€140,166
new in 2025: €140,166
- Cash +€139,117
up €139,117 (+472.1%), from €29,467 to €168,584
mainly Current investments (+€220,000) and Net result for the year (+€153,085)
- Profit (loss) carried forward +€153,085
up €153,085 (+84.1%), from €182,056 to €335,141
- Accrued charges and deferred income -€79,887
down €79,887 (-91.0%), from €87,811 to €7,924
- Financial income +€1,130
up €1,130 (+0.8%), from €140,696 to €141,826
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,826,840 | €1,886,123 | +€59,283 | +3.2% |
| Fixed assets | 21/28 | €1,577,373 | €1,577,373 | = | 0.0% |
| Financial fixed assets | 28 | €1,577,373 | €1,577,373 | = | 0.0% |
| Current assets | 29/58 | €249,467 | €308,749 | +€59,283 | +23.8% |
| Amounts receivable within one year | 40/41 | - | €140,166 | +€140,166 | |
| Other amounts receivable | 41 | - | €140,166 | +€140,166 | |
| Current investments | 50/53 | €220,000 | - | -€220,000 | |
| Cash at bank and in hand | 54/58 | €29,467 | €168,584 | +€139,117 | +472.1% |
| Total equity and liabilities | 10/49 | €1,826,840 | €1,886,123 | +€59,283 | +3.2% |
| Equity | 10/15 | €200,606 | €353,691 | +€153,085 | +76.3% |
| Contributions | 10/11 | €18,550 | €18,550 | = | 0.0% |
| Profit (loss) carried forward | 14 | €182,056 | €335,141 | +€153,085 | +84.1% |
| Amounts payable | 17/49 | €1,626,233 | €1,532,431 | -€93,802 | -5.8% |
| Amounts payable after more than one year | 17 | €1,481,500 | €1,481,500 | = | 0.0% |
| Financial debts | 170/4 | €1,481,500 | €1,481,500 | = | 0.0% |
| Amounts payable within one year | 42/48 | €56,922 | €43,007 | -€13,915 | -24.4% |
| Taxes, remuneration and social security | 45 | €298 | - | -€298 | |
| Taxes | 450/3 | €298 | - | -€298 | |
| Other amounts payable | 47/48 | €56,624 | €43,007 | -€13,617 | -24.0% |
| Accrued charges and deferred income | 492/3 | €87,811 | €7,924 | -€79,887 | -91.0% |
| Other operating charges | 640/8 | €118 | €120 | +€2 | +1.7% |
| Gross operating margin | 9900 | €23,848 | €23,935 | +€87 | +0.4% |
| Operating profit (loss) | 9901 | €23,730 | €23,815 | +€85 | +0.4% |
| Financial income | 75/76B | €140,696 | €141,826 | +€1,130 | +0.8% |
| Recurring financial income | 75 | €140,696 | €141,826 | +€1,130 | +0.8% |
| Financial charges | 65/66B | €8,197 | €8,112 | -€84 | -1.0% |
| Recurring financial charges | 65 | €8,197 | €8,112 | -€84 | -1.0% |
| Profit (loss) for the period before taxes | 9903 | €156,229 | €157,529 | +€1,300 | +0.8% |
| Income taxes | 67/77 | €4,217 | €4,444 | +€227 | +5.4% |
| Profit (loss) for the period | 9904 | €152,012 | €153,085 | +€1,073 | +0.7% |
| Profit (loss) for the period to be appropriated | 9905 | €152,012 | €153,085 | +€1,073 | +0.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.